Humoral immune response to p53 in malignant glioma

被引:17
作者
Weller, M
Bornemann, A
Stander, M
Schabet, M
Dichgans, J
Meyermann, R
机构
[1] Univ Tubingen, Neurol Klin, D-72076 Tubingen, Germany
[2] Univ Tubingen, Sch Med, Brain Res Inst, D-72076 Tubingen, Germany
关键词
glioma; p53; immune; transforming growth factor-beta (TGF-beta); antibody;
D O I
10.1007/s004150050199
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
p53 immunoreactivity and humoral immune response to p53 were examined in 14 patients with malignant glioma, including 4 patients with Ieptomeningeal glioma cell dissemination. Twelve patients expressed p53 protein within the tumour tissue. p53 antibodies were detected in the serum in 2 of 14 patients but never in the cerebrospinal fluid (CSF). Soluble p53 protein was detected neither in serum nor in CSF of the glioma patients. CSF levels of the immunosuppressive cytokine, transforming growth factor (TGF)-beta, were elevated in the glioma patients, including those with a humoral response to p53. These preliminary findings raise the possibility of systemic humoral immune responses to antigens, including mutant p53, expressed by glioma cells in the central nervous system.
引用
收藏
页码:169 / 172
页数:4
相关论文
共 17 条
[1]   PREVALENCE OF SERUM ANTIBODIES AGAINST THE P53 TUMOR-SUPPRESSOR GENE PROTEIN IN VARIOUS CANCERS [J].
ANGELOPOULOU, K ;
DIAMANDIS, EP ;
SUTHERLAND, DJA ;
KELLEN, JA ;
BUNTING, PS .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (04) :480-487
[2]   THE P53 GENE AND ITS ROLE IN HUMAN BRAIN-TUMORS [J].
BOGLER, O ;
HUANG, HJS ;
KLEIHUES, P ;
CAVENEE, WK .
GLIA, 1995, 15 (03) :308-327
[3]  
CONSTAM DB, 1992, J IMMUNOL, V148, P1404
[4]   DETECTION OF ANTIBODIES AGAINST THE CELLULAR PROTEIN P53 IN SERA FROM PATIENTS WITH BREAST-CANCER [J].
CRAWFORD, LV ;
PIM, DC ;
BULBROOK, RD .
INTERNATIONAL JOURNAL OF CANCER, 1982, 30 (04) :403-408
[5]  
GREENBLATT MS, 1994, CANCER RES, V54, P4855
[6]   p53 protein is absent from the serum of patients with lung cancer [J].
Levesque, MA ;
DCosta, M ;
Diamandis, EP .
BRITISH JOURNAL OF CANCER, 1996, 74 (09) :1434-1440
[7]  
LUBIN R, 1993, CANCER RES, V53, P5872
[8]  
Lubin R, 1995, CLIN CANCER RES, V1, P1463
[9]   Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines [J].
Mayordomo, JI ;
Loftus, DJ ;
Sakamoto, H ;
DeCesare, CM ;
Appasamy, PM ;
Lotze, MT ;
Storkus, WJ ;
Appella, E ;
DeLeo, AB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1357-1365
[10]   p53 as a target for cancer vaccines: Recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge [J].
Roth, J ;
Dittmer, D ;
Rea, D ;
Tartaglia, J ;
Paoletti, E ;
Levine, AJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (10) :4781-4786